UroGen Pharma Ltd.
Nasdaq: URGN
——
The chart fills in as daily closes arrive.
52-week range — – —
End-of-day prices. Not live quotes, and not investment advice.
Funding and exits
No funding round or acquisition of UroGen Pharma Ltd. has been reported on this site yet.
UroGen Pharma Ltd. in the news
No business news about UroGen Pharma Ltd. yet.
More in Pharma & biotech
| Company | Industry | Listed | Close | Day | Market value |
|---|---|---|---|---|---|
| BioLineRx Ltd. | Pharma & biotech | Nasdaq: BLRX | — | — | — |
| Can-Fite BioPharma Ltd. | Pharma & biotech | NYSE: CANF | — | — | — |
| Chemomab Therapeutics Ltd. | Pharma & biotech | Nasdaq: CMMB | — | — | — |
| Compugen Ltd. | Pharma & biotech | Nasdaq: CGEN | — | — | — |
| Enlivex Ltd. | Pharma & biotech | Nasdaq: ENLV | — | — | — |
| Entera Bio Ltd. | Pharma & biotech | Nasdaq: ENTX | — | — | — |